Leslie Donato
President & Chief Strategy Officer at Cencora
Greater Philadelphia
Overview
Work Experience
Member Board of Trustees
2022 - Current
Audit and Innovation Committees
Board Member
2023 - 2024
Compensation Committee M&A Committee
OneOncology is a partnership of oncologists and industry leading experts driving the future of community-based cancer care in the US.
Executive Vice President & Chief Strategy Officer
2019 - 2024
Transformed Corporate Strategy, Corporate Development, and Innovation functions. Member of Executive Committee. Cencora representative to One Oncology Board and Healthcare Leadership Council.
Cencora is a global healthcare company that advances the development and delivery of pharmaceuticals and healthcare products.
Raised $3,025,000,000.00.
Board Member
2019 - 2022
Chair of Audit Committee; Compensation Committee
Vice President Strategy, Pharmaceuticals
2015 - 2019
Lead the development of an integrated (research, development, commercial) global pharmaceutical strategy in 2014 and a US growth strategy. Responsible for supporting the CEO of the Pharmaceutical Division in defining the long-range strategy and executing key strategic projects. Lead strategy development across business segments and functions. Supported portfolio investment decisions through leadership of the holistic portfolio review process and as a member of the Global Product Development Committee.
Vice President and General Manager, Hematology and Neurology, United States
2011 - 2015
Lead the Specialty Therapeutics Business Unit, comprising of Hematology and Neurology Portfolio.
Vice President Neurology, Head Global Brand Team Betaferon
2010 - 2011
Lead Neurology Therapeutic Area with global revenues over €1.2 billion driven by Bayer’s largest pharmaceutical brand, Betaferon. Responsible for developing and driving global brand and therapeutic area strategy. Lead cross-functional global brand team (Betaferon).
Global Head of Regional Business Units, Specialty Medicine Business Unit
2009 - 2010
Responsible for leading the regional business units of the Specialty Medicine Business Unit. The Business Unit comprises several therapeutic areas including Oncology, Hematology, Neurology and Ophthalmology. The Regional Business Units (RBUs) customize global brand strategy to reflect regional market dynamics and partner with country leadership to execute these strategies.
Principal
1995 - 2009
Lead engagements across multiple clients to guide top management in generating positive and lasting impact. A leader in McKinsey's Pharmaceutical and Medical Products Practice specializing in Strategy, Marketing, Sales, Business Development and Organizational Effectiveness. Beyond pharmaceuticals, also led work in consumer health and the generics industry. A founding Partner of the Philadelphia Office and leader of the Mid-Atlantic Offices Womens' Initiative
McKinsey Growth Tech serves leading growth stage tech players, venture capital, and growth private equity
Business Analyst
1991 - 1993
Developed diversified skill set and broad management perspective through projects spanning a spectrum of management functions and industries including manufacturing, financial services, public sector, and health-care. Major functions included: business process reengineering, new product development, and strategy.
Deloitte Tax is an advisory firm that provides tax preparation and advisory services.